Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery

• Published in: Journal of nanobiotechnology Vol. 21; no. 1; p. 16
• Main Authors: Bao, Xiaoyan, Qian, Kang, Xu, Mengjiao, Chen, Yi, Wang, Hao, Pan, Ting, Wang, Zhengyi, Yao, Ping, Lin, Li
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.01.2023; BioMed Central; BMC
• Subjects: Animals; Care and treatment; Cholic Acid; Diabetes Mellitus, Type 2; Diagnosis; Dosage and administration; Evaluation; Glycolipids; Hypoglycemic agents; Hypoglycemic Agents - pharmacology; Intestinal Mucosa; Liraglutide; Liraglutide - pharmacology; Methods; Mice; Molecular Docking Simulation; Nanocomposites; Oral; Patient compliance; Rhamnolipids; Simulation methods; Type 2 diabetes; Zein - chemistry; China; Type 2 diabetes; Cholic acid; Oral; Rhamnolipids; Liraglutide
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-022-01743-9

Oral administration offered a painless way and improved compliance for diabetics. However, the emerging GLP-1 analog peptide drugs for diabetes primarily rely on the injection route, and the development of oral dosage forms was hampered by the low oral bioavailability due to the structural vulnerability to digestive enzymes and molecule impermeability in the gastrointestinal tract. In this study, the non-covalent interaction between cholic acid (CA) and liraglutide (LIRA) was found and theoretically explained by molecular docking simulation. Formation of this physical complex of liraglutide and cholic acid (LIRA/CA Complex) reduced the self-aggregation of LIRA and accelerated intestinal epithelium penetration. By the anti-solvent method, LIRA/CA Complex was loaded into zein/rhamnolipids nanoparticles (LIRA/CA@Zein/RLs) with a loading efficiency of 76.8%. LIRA was protected from fast enzymatic degradation by the hydrophobic zein component. Meanwhile, Rhamnolipids, a glycolipid with surface activity, promoted endocytosis while also stabilizing the nanoparticles. The two components worked synergistically to ensure the delivery of LIRA/CA Complex to intestinal villi and improved oral absorption without disrupting tight junctions. LIRA/CA@Zein/RLs demonstrated a considerable intestinal epithelium absorption in mouse gastrointestinal section and a retention in vivo over 24 h, resulting in a significant and long-lasting hypoglycemic effect in Type 2 diabetes mice. This study provided a promising oral delivery approach for LIRA and exhibited the potential for further translation into clinical application.